Most US Dermatologists Prescribe Baricitinib for Alopecia Areata, Report Shows
Baricitinib is more commonly prescribed by dermatologists for patients with alopecia in the United States and is projected to maintain a substantial market lead over ritlecitinib.
Read More
High Levels of Cholesterol, Low-Density Lipoprotein Cholesterol, Among Genetic Risk Factors for Psoriasis
Investigators explored the genetic relationship between psoriatic disease and serum lipid levels.
Dermatologists Play Crucial Role in Support and Inclusivity of Transgender and Gender-Diverse Patients
Understanding the needs of gender-diverse patients and patients receiving gender-affirming hormones is crucial to equitable care and properly addressing patients' needs.
FDA Accepts sBLA for Interchangeability Designation for Adalimumab-bwwd
HADLIMA is currently indicated for psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa, among others.
More Than Half of Adults With Moderate to Severe AD Report Conditions That May Influence Selection of JAK Inhibitors
The most common conditions or concerns patients with atopic dermatitis (AD) reported having that may influence their selection of a JAK inhibitor included an increased risk of MACE and an age above 65 years.
Study Explores Dermatologic Patient Journey to Enhance Patient Care and Address Unmet Needs
A European Academy of Dermatology and Venereology study explored the pathway from dermatologic consult to diagnosis to treatment and outcomes in the health care system.
Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis, Study Says
Investigators found a steady reduction of immunoglobulin E (IgE) levels in patients regardless of dupilumab dosing interval.
Atopic Dermatitis, Systemic Inflammation Not Linked to Dementia Risk
According to researchers, only 3 studies have previously explored a potential link between AD and dementia with inconsistent findings.
Digital Health Interventions May Improve Efficacy, Efficiency of Care in Dermatology
Researchers conducted systematic mapping of relevant digital health intervention literature to determine the impact of these interventions on dermatologic care outcomes.
Increasing Awareness of Gender-Diverse Patient Concerns in Dermatology
Matthew Mansh, MD, FAAD, discusses inequities faced by transgender and gender-diverse patient populations.
Scientists Identify Treatment Option for Rare Pansclerotic Morphea
Scientists have found a new therapy for the severe inflammatory skin disorder.
European Commission Approves Secukinumab for Hidradenitis Suppurativa
The approval makes the drug Europe’s first and only interleukin (IL)-17A inhibitor approved for the condition.